Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse

Reykjavík, Iceland (ots/PRNewswire) – – The Aztiq-Innobic consortium will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceutical and the sole shareholder in Adalvo – Róbert Wessman, chairman and CEO of Alvogen and founder of Aztiq, will continue as chairman of the board of Lotus and Adalvo.

Read the source article at mycity24.at
2021-11-26 00:00:00